Header Logo

Connection

Kyle Amber to Immunotherapy

Back to Details
This is a "connection" page, showing publications Kyle Amber has written about Immunotherapy.
Kyle Amber
Connection Strength
0.234
Immunotherapy
  1. Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. Br J Dermatol. 2023 Dec 20; 190(1):137-138.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.